Filters

Olli Kallioniemi, Spyro Mousses, Laurence J Miller, Ishaiahu Shechter, Patricia E Carrigan, Cumhur Ekmekçi, Aprill Watanabe, Galen Hostetter, Şükrü Tüzmen

Personalized medicine 2019;16(1):51-65

Full Text

Abstract

Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia.

Evan A Stein, Harold Bays, Dennis O'Brien, Jim Pedicano, Edward Piper, Andrea Spezzi

Circulation 2011;123(18):1974-85

Full Text

Abstract

New lipid-lowering drugs: an update.

A S Wierzbicki, T C Hardman, A Viljoen

International journal of clinical practice 2012;66(3):270-80

Full Text

Abstract

Quantitative transcript profiling reveals down-regulation of A sterol pathway relevant gene and overexpression of artemisinin biogenetic genes in transgenic Artemisia annua plants.

Rui-Yi Yang, Li-Ling Feng, Xue-Qin Yang, Lu-Lu Yin, Xiao-Ling Xu, Qing-Ping Zeng

Planta medica 2008;74(12):1510-6

Full Text

Abstract

The treatment of dyslipidemia--what's left in the pipeline?

Oliver Rau, Heiko Zettl, Laura Popescu, Dieter Steinhilber, Manfred Schubert-Zsilavecz

ChemMedChem 2008;3(2):206-21

Full Text

Abstract

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Elliot Stieglitz, Ashley F Ward, Robert B Gerbing, Todd A Alonzo, Robert J Arceci, Y Lucy Liu, Peter D Emanuel, Brigitte C Widemann, Jennifer W Cheng, Nalini Jayaprakash, Frank M Balis, Robert P Castleberry, Nancy J Bunin, Mignon L Loh, Todd M Cooper

Pediatric blood & cancer 2015;62(4):629-36

Free Full Text

Abstract

Results: 1 – 15 / 17

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Farnesyl-Diphosphate Farnesyltransferase""[mesh_terms]

Terpene biosynthesis: modularity rules.

Total synthesis of the squalene synthase inhibitor zaragozic acid C.

The return of two old targets?

Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia.

A highly selective biosynthetic pathway to non-natural C50 carotenoids assembled from moderately selective enzymes.

1-Azaadamantanes: pharmacological applications and synthetic approaches.

Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice.

Human cholesterol metabolism and therapeutic molecules.

Advancing therapy for hypercholesterolemia.

Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.

Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia.

New lipid-lowering drugs: an update.

Quantitative transcript profiling reveals down-regulation of A sterol pathway relevant gene and overexpression of artemisinin biogenetic genes in transgenic Artemisia annua plants.

The treatment of dyslipidemia--what's left in the pipeline?

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Results for

""Farnesyl-Diphosphate Farnesyltransferase""[mesh_terms]